Suchergebnisse - "Yoshimura, Ryoichi"

PubPharm (129)

21

Localization of substance P (SP)-immunoreactivity in the myenteric plexus of the rat esophagus

enthalten in: Histochemistry and cell biology | 2022

von Morishita, R. | Yoshimura, R. | Sakamoto, H. | +1

22

Role of TRPM8 in cold avoidance behaviors and brain activation during innocuous and nocuous cold stimuli

enthalten in: Physiology & behavior | 2022

von Kasuga, R. | Shiraki, C. | Horikawa, R. | +3

23

Microglial proliferation attenuates sickness responses in adult mice during endotoxin-induced inflammation

enthalten in: Journal of neuroimmunology | 2022

von Torii, K. | Takagi, S. | Yoshimura, R. | +1

24

Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial

enthalten in: Journal of hepato-biliary-pancreatic sciences | 2022

von Kudo, A. | Tateishi, U. | Yoshimura, R. | +10

25

Focal brachytherapy for localized prostate cancer : 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy

enthalten in: Urologic oncology | 2022

von Matsuoka, Y. | Uehara, S. | Toda, K. | +7

26

A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [18F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose

enthalten in: Diagnostics (Basel, Switzerland) | 2022

von Usami, A. | Yokoyama, K. | Tsuchiya, J. | +4

27

Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer : a single-institutional study

enthalten in: Japanese journal of clinical oncology | 2022

von Sasamura, K. | Soyano, T. | Kozuka, T. | +6

28

Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

enthalten in: Cancers | 2022

von Yoshida, S. | Takahara, T. | Arita, Y. | +7

29

Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer

enthalten in: European radiology | 2022

von Kimura, K. | Yoshida, S. | Tsuchiya, J. | +7

30

MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma

enthalten in: Oral oncology | 2022

von Noji, R. | Kano, Y. | Hirai, H. | +6